Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 2/20 | 0.51 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24473720 | 0.84 | KEAP1 (0.60) | KEAP1NFE2L2 | |
| SCHEMBL29698480 | 0.83 | KEAP1 (0.47) | KEAP1NFE2L2 | |
| SCHEMBL26859864 | 0.82 | KEAP1 (0.43) | KEAP1NFE2L2 | |
| SCHEMBL19129823 | 0.81 | KEAP1 (0.59) | KEAP1NFE2L2 | |
| SCHEMBL13532042 | 0.81 | KEAP1 (0.59) | KEAP1NFE2L2 | |
| SCHEMBL26859845 | 0.78 | KEAP1 (0.41) | KEAP1NFE2L2 | |
| SCHEMBL26860470 | 0.76 | KEAP1 (0.61) | KEAP1NFE2L2 | |
| SCHEMBL29698445 | 0.76 | KEAP1 (0.61) | KEAP1NFE2L2 | |
| SCHEMBL26859849 | 0.73 | KEAP1 (0.39) | KEAP1NFE2L2 | |
| SCHEMBL26859851 | 0.73 | KEAP1 (0.39) | KEAP1NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260043057-A1 | ENZYMATIC SYNTHESIS OF MYCOSPORINE-LIKE AMINO ACIDS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2026-02-12 | — | — | US | disclosed |
| EP-4644328-A2 | ZINC OXIDE PARTICLES, PHOTOSTABLE UV FILTERS, AND METHODS OF USE THEREOF | NANOPHASE TECHNOLOGIES CORPORATION (US) | 2025-11-05 | — | — | EP | disclosed |
| EP-3943450-B1 | ZINC OXIDE PARTICLES, PHOTOSTABLE UV FILTERS, AND METHODS OF USE THEREOF | SOLESENCE INC (US) | 2025-09-03 | — | — | EP | disclosed |
| CN-120117644-A | Zinc oxide particles, photostable UV filters, and methods of use thereof | 纳米技术有限公司 | 2025-06-10 | — | — | CN | disclosed |
| US-20250170036-A1 | ZINC OXIDE PARTICLES, PHOTOSTABLE UV FILTERS, AND METHODS OF USE THEREOF | Solésence, Inc. | 2025-05-29 | — | — | US | disclosed |
| US-20240376504-A1 | ENZYMATIC SYNTHESIS OF MYCOSPORINE-LIKE AMINO ACIDS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-11-14 | — | — | US | disclosed |
| US-12083200-B2 | Zinc oxide particles, photostable UV filters, and methods of use thereof | NANOPHASE TECHNOLOGIES CORPORATION (US) | 2024-09-10 | — | — | US | disclosed |
| WO-2024026353-A2 | ENZYMATIC SYNTHESIS OF MYCOSPORINE-LIKE AMINO ACIDS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-02-01 | — | — | WO | disclosed |
| WO-2023230336-A2 | BIOCATALYTIC SYNTHESIS OF UNNATURAL MYCOSPORINE-LIKE AMINO ACIDS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-11-30 | — | — | WO | disclosed |
| US-20230363990-A1 | ZINC OXIDE PARTICLES, PHOTOSTABLE UV FILTERS, AND METHODS OF USE THEREOF | Solésence, Inc. | 2023-11-16 | — | — | US | disclosed |
| CN-116261553-A | Zinc oxide particles, photostable UV filters, and methods of use thereof | 纳米技术有限公司 | 2023-06-13 | — | — | CN | disclosed |
| US-11672744-B2 | Zinc oxide particles, photostable UV filters, and methods of use thereof | NANOPHASE TECHNOLOGIES CORPORATION (US) | 2023-06-13 | — | — | US | disclosed |
| US-20230039255-A1 | COATED POWDERS HAVING HIGH PHOTOSTABILITY | NANOPHASE TECH CORPORATION (US) | 2023-02-09 | — | — | US | disclosed |
| US-11499054-B2 | Coated powders having high photostability | NANOPHASE TECHNOLOGIES CORPORATION (US) | 2022-11-15 | — | — | US | disclosed |
| WO-2022217117-A1 | ENZYMATIC SYNTHESIS OF MYCOSPORINE-LIKE AMINO ACIDS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2022-10-13 | — | — | WO | disclosed |
| EP-3943450-A1 | ZINC OXIDE PARTICLES, PHOTOSTABLE UV FILTERS, AND METHODS OF USE THEREOF | NANOPHASE TECHNOLOGIES CORPORATION (US) | 2022-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260043057-A1 | ENZYMATIC SYNTHESIS OF MYCOSPORINE-LIKE AMINO ACIDS | ALAD, AHCY, DAO | KEAP1 590/4885NFE2L2 1089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.